Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles

Pharmaceutical Compositions Comprising Danazol

ABUSE-PROOFED ORAL DOSAGE FORM

USE OF RANOLAZINE FOR THE TREATMENT OF CORONARY MICROVASCULAR DISEASES

Controlled Release Formulation

FORM OF ADMINISTRATION SECURED AGAINST MISUSE

PROCESS FOR PRODUCING SOLID ORAL DOSAGE FORMS WITH SUSTAINED RELEASE OF ACTIVE INGREDIENT

Ingestible formulations for transient, noninvasive reduction of gastric volume

BENZOYLGUANIDINE SALT AND HYDRATES THEREOF

Controlled release solid dispersions

Stable Solid Oral Dosage Forms of Valsartan

Controlled Release Pharmaceutical Compositions of Tolperisone for Oral Administration

Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles

Pharmaceutical composition of quetiapine fumarate

Active Agent Formulations, Methods of Making, and Methods of Use

EXTENDED RELEASE MATRIX FORMULATIONS OF MORPHINE

System for manufacturing controlled release dosage forms, such as zero-order release profile dosage form manufactured by three-dimensional printing

Colonic purgative composition with soluble binding agent

Method for stabilizing anti-dementia drug

Pharmaceutical formulations of modafinil

CONTROLLED RELEASE FORMULATIONS OF AN ALPHA-ADRENERGIC RECEPTOR ANTAGONIST

Pharmaceutical composition

Modified Release Ciprofloxacin Compositions

Preventive/Therapeutic Composition For Free Radical Disease

Indications for Direct Thrombin Inhibitors

USE OF RANOLAZINE FOR THE TREATMENT OF NON-CORONARY MICROVASCULAR DISEASES

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

Pharmaceutical Composition Comprising an Indolylmaleimide Derivative

PHARMACEUTICAL COMPOSITIONS COMPRISING MEMANTINE

VAGINALLY ADMINISTERED ANTI-DYSRHYTHMIC AGENTS FOR TREATING PELVIC PAIN

SOLID PHARMACEUTICAL DOSAGE FORMULATIONS

Controlled release dosage form of tacrolimus

Sirolimus formulation

Treatment of Pain

MODIFIED RELEASE COMPOSITION OF AT LEAST ONE FORM OF VENLAFAXINE

Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same

Celecoxib compositions

VALACYCLOVIR COMPOSITIONS

Rapidly Disintegrating Dosage Form Comprising Magnesium Carbonate Heavy

Orally bioavailable CCI-779 formulations

Methods and compositions for deterring abuse of orally administered pharmaceutical products

Methods of stabilizing azithromycin

DARUSENTAN ORAL DOSAGE FORM

Tablets comprising entacapone and crospovidone

DIPHOSPHONIC ACID PHARMACEUTICAL COMPOSITIONS

Sustained release alfuzosin hydrochl formulation and method for their production

PHARMACEUTICAL DOSAGE FORMS OF OXCARBAZEPINE

Separable solid dosage form administration system

Tablets comprising a biologically active substance and an excipient containing calcium carbonate

N-Arylshydroxyalkylidene carboxamide compositions and methods

Finely divided composition containing poorly water soluble substance

IBUPROFEN COMPOSITION

DPP IV INHIBITOR FORMULATIONS

Solid Pharmaceutical Composition Comprising Valsartan

Quick Dissolve Medicament and Method of Manufacturing

Amorphous Composition

SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS OF ALFUZOSIN AND PROCESS FOR PREPARATION THEREOF

Method and formulation for treating resistance to antihypertensives and related conditions

CAPECITABINE RAPIDLY DISINTEGRATING TABLETS

Controlled Long Acting Release Pharmaceutical Preparation For Use In The Oral Cavity

Modified release formulations of a bupropion salt

CONTROLLED RELEASE HYDROGEL FORMULATION

New Oral Formulation

HYDROPHILIC OPIOID ABUSE DETERRENT DELIVERY SYSTEM USING OPIOID ANTAGONISTS

HYDROPHILIC ABUSE DETERRENT DELIVERY SYSTEM

Psychostimulant containing pharmaceutical composition

HYDROPHOBIC OPIOID ABUSE DETERRENT DELIVERY SYSTEM USING OPIOID ANTAGONISTS

Abuse-resistant controlled-release opioid dosage form

HYDROPHOBIC ABUSE DETERRENT DELIVERY SYSTEM

Process for preparing fenofibrate compositions

Fenofibrate compositions

Prolonged-release multimicroparticulate oral pharmaceutical form

Controlled release nisoldipine compositions

Pharmaceutical Compositions

Controlled Release Formulations

Modified release formulations of a bupropion salt

COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE NIGHT INSOMNIA

Modified release formulations of a bupropion salt

STABILIZED EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING AN AMG-COA REDUCTASE INHIBITOR

Active Agent Formulations, Methods of Making, and Methods of Use

Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia

Processes For The Preparation Of Oral Dosage Formulations Of Modafinil

Modified release formulations of a bupropion salt

Modified release formulations of a bupropion salt

Extended release tablet formulations of flibanserin and method for manufacturing the same

Modified release formulations of a bupropion salt

Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent

Modified release formulations of a bupropion salt

Modified release formulations of a bupropion salt

Fluvastatin sodium pharmaceutical compositions

Novel anelgesic combination

High dose orally dissolvable/disintegrable lyophilized dosage form

Sustained-release bupropion and bupropion/mecamylamine tablets

Orally dissolvable/disintegrable lyophilized dosage forms containing protected

IMMEDIATE-RELEASE TABLET FORMULATIONS OF A THROMBIN RECEPTOR ANTAGONIST

SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

Methods and compositions employing bicifadine for the treatment of acute pain, chronic pain, and symptoms of neuropathic disorders

BENZOYLGUANIDINE SALT AND HYDRATES THEREOF

Controlled release formulations and associated methods

Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers

HYDROPHOBIC ABUSE DETERRENT DELIVERY SYSTEM FOR HYDROMORPHONE

Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels

PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE OF AN INSULIN SENSITISER AND ANOTHER ANTIDIABETIC AGENT

PHARMACEUTICAL COMPOSITION AS SOLID DOSAGE FORM AND METHOD FOR MANUFACTURING THEREOF

Rapidly disintegrating tablet containing polyvinyl alcohol

Method of treating diabetes

Pharmaceutical compositions of memantine

Orally Dissolving Formulations of Memantine

Method of preparing a taste-masking oral dosage form

Particulates

Extended Release Pharmaceutical Composition of Celecoxib

Controlled-Release Formulation Comprising Tamsulosin Hydrochloride

Modified release formulations of a bupropion salt

Novel Extended Release Composition of Venlafaxine Hydrochloride Containing Polyvinyl Acetate

Processes for the Preparation of Solid Dosage Forms of Amorphous Valganciclovir Hydrochloride

Compositions and methods of treating middle-of-the night insomnia

PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE INSULIN SENSITISER

Sustained release formulation of naltrexone

Sustained release formulations of opioid and nonopioid analgesics

Sustained release oxycodone composition with acrylic polymer and metal hydroxide

Sustained release oxycodone composition with acrylic polymer and surfactant

MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT

Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Modified release formulations of a bupropion salt

Controlled release oxycodone compositions

PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS OF METFORMIN EXTENDED RELEASE TABLETS

Flashmelt oral dosage formulation

Formulation and process for the preparation of modafinil

Method for treating minor aphthous ulcers

Modified release formulations of a bupropion salt

Tablet composition with a prolonged release of tamsulosin

SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN

Sustained Release Pharmaceutical Formulation

PHARMACEUTICAL FORMULATIONS OF PIMAVANSERIN

Calcium compositions

Methods and compositions for deterring abuse of opioid containing dosage forms

Novel triptan formulations and methods for making them

Modified-release preparations containing oxcarbazepine and derivatives thereof

Metaxalone formulations and methods for the preparation thereof

Inhibitors of crystallization in a solid dispersion

Compositions comprising co-precipitate of eplerenone and a water-soluble excipient

Utilization of dialkylfumarates

Utilization of dialkylfumarates

Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose

Rapidly disintegrating solid oral dosage form of liquid dispersions

Solid oral dosage form containing an enhancer

Sustained-release preparations of quinolone antibiotics

Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor

Controlled-release formulation of HCV protease inhibitor and methods using the same

Methods for Treating Hyperlipidemia With Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics

Oral administration of calcitonin

Controlled-release dosage forms comprising zolpidem or a salt thereof

Methods and compositions for deterring abuse of orally administered pharmaceutical products

Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor

Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor

COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE NIGHT INSOMNIA

Sustained-Release Preparations Containing Topiramate and the Producing Method Thereof

Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor

Controlled Release Pharmaceutical Formulation

Process for preparing oral calcium compositions

Modified release formulations containing drug-ion exchange resin complexes

Controlled Release Matrix Pharmaceutical Dosage Formulation

Tablet Formulations and Processes

Pharmaceutical composition and process

SOLID-STATE FORM OF CELECOXIB HAVING ENHANCED BIOAVAILABILITY

Methods of stabilizing azithromycin

Galenic formulations of organic compounds

LOW-FRIABILITY, PATIENT-FRIENDLY ORALLY DISINTEGRATING FORMULATIONS

Oral matrix formulations comprising licarbazepine

Rapidly dissolving tablets comprising low surface area calcium phosphates

Rapidly dissolving tablets comprising low surface area titanium dioxide

Controlled release pharmaceutical compositions with improved bioavailability

Dosage forms for the delivery of drugs of abuse and related methods

Pharmaceutical Composition in the Form of a Gastric-Resident Tablet Containing an Active Principle

Delayed release pharmaceutical oral dosage form and method of making same

Process for producing fenofibrate tablets

Sustained release dosage forms of ziprasidone

Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

Controlled release formulation for oral administration of metformin

Pharmaceutical composition and process

Dipyridamole extended-release formulations and process for preparing same

Stable pharmaceutical formulations of montelukast sodium

Moisture resistant container systems for rapidly bioavailable dosage forms

Blister packaging for acute pain regimens

Process for producing fenofibrate tablets

Stable pharmaceutical formulations of montelukast sodium

DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE

Abuse-proofed dosage form

Spray dried pharmaceutical compositions

Solid pharmaceutical preparation

Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient

Methods and compositions for deterring abuse of opioid containing dosage forms

Nanoparticulate and controlled release compositions comprising a cephalosporin

N-arylshydroxyalkylidene-carboxamide compositions and methods

Gastric release pulse system for drug delivery

Pharmaceutical composition which reduces or eliminates drug abuse potential

Pharmaceutical formulations of fenofibrate having improved bioavailability

Pharmaceutical composition

Oral paracetamol formulations

Opioid formulations having reduced potential for abuse

BETA-LACTAM ANTIBIOTIC-CONTAINING TABLET AND PRODUCTION THEREOF

Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate

Sustained release formulations

Extended release dosage form

Compositions and methods for treating middle-of-the-night insomnia

Taste masking composition

Composition having liver function protecting effect

RAPIDLY ABSORBING ORAL FORMULATIONS OF PDE 5 INHIBITORS

QUININE DOSAGE FORMS AND METHODS OF USE THEREOF

Pharmaceutical compositions comprising meloxicam and methods of their preparation

Pharmaceutical compositions of telmisartan

Atorvastatin formulation

Delayed release tablet with defined core geometry

Modified release tablet formulations with enhanced mechanical properties

Modified release composition of at least one form of venlafaxine

Modified release compositions for DPP-IV inhibitors

Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject

Compositions of estrogen-cyclodextrin complexes

Crystalline forms of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester

Pharmaceutical composition

GELLING COMPOSITIONS AND METHODS

PHARMACEUTICAL COMPOSITIONS

In VIVO formed matrices including natural biodegradale polysaccharides and ophthalmic uses thereof

Methods of treating middle-of-the-night insomnia

Controlled delivery creatine formulations and method of using the same

Novel controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum

Method of preparing sustained-release preparations of quinolone antibiotics

In situ occlusion using natural biodegradable polysaccharides

In vivo formed matrices including natural biodegradable polysaccharides and uses thereof

Articles including natural biodegradable polysaccharides and uses thereof

Coatings including natural biodegradable polysaccharides and uses thereof

Process and apparatus for forming agglomerates of a powder composition of an active and binder

Drug Delivery System and Associated Methods

SUSTAINED RELEASE DOSAGE FORMS OF OXCARBAZEPINE

Pharmaceutical compositions

PHARMACEUTICAL COMPOSITIONS

Methods for promoting growth of bone, ligament, and cartilage

Drug compositions containing controlled release hypromellose matrices

Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily

Mucosal delivery tablet

Free flowing granules containing carbomer

ABUSE-PROOFED DOSAGE FORM

Matrix compositions for controlled delivery of drug substances

Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof

Rapidly dispersing/disintegrating compositions

Film-coated tablet or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this compound

Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator

Rapidly absorbing oral formulations of PDE 5 inhibitors

Modified release formulations of a bupropion salt

Benzoquinones of enhanced bioavailability

Preparation of pharmaceutical compositions containing nanoparticles

Pharmaceutical formulation containing irritant

Bioresorbable hydrogel compositions for implantable prostheses

STABLE DESLORATADINE COMPOSITIONS

Novel granulation process

Pharmaceutical dosage form containing novel pharmaceutical granulate

Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent

Controlled drug release composition resistant to in vivo mechanic stress

ACE inhibitor formulation

Drug delivery device

Modified release compositions comprising tacrolimus

Compositions and methods of treating middle-of-the night insomnia

Attachment of a handle to a solid oral dosage form

Sustained release formulations

Solid compositions for treating middle-of-the-night insomnia

Polymer complexes of glucuronoglucanes

Pharmaceutical formulation

Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

Quinine dosage forms and methods of use thereof

Antifungal compositions with improved bioavailability

Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics

Quinine formulations

Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles

Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent

Deramciclane-fumarate tablets

Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy

Stability of progestogen formulations

Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier

Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration

Pharmaceutical composition as solid dosage form and method for manufacturing thereof

Growth-promoting and immunizing subcutaneous implant

Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the same

Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins

Aliphatic amine polymer salts for tableting

SYSTEMS, METHODS AND APPARATUSES FOR MANUFACTURING DOSAGE FORMS

Sustained release formulations of venlafaxine

Binders for tablets with high strength based on finely divided vinyllactam polymers, the production and use thereof

Pharmaceutical composition as solid dosage form and method for manufacturing thereof

Controlled release dosage forms

Controlled released dosage forms

Extended release formulation of beta-lactam antibiotics

Coating composition

Composition for improving cognition and memory

Modified release tablet of bupropion hydrochloride

Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs

Sustained release ranolazine formulations

Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms

Sustained release delivery of isradipine

Control release formulation containing a hydrophobic material as the sustained release agent